Inmaculada Alés

机构：Universidad de Málaga

发表论文 12 篇 · 总被引 384 次 · h-index 7

代表论文

• Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial (2022 · Journal of Clinical Oncology · 被引 136)
• Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer (2011 · Clinical & Translational Oncology · 被引 80)
• Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial (2019 · ˜The œLancet. Gastroenterology & hepatology · 被引 61)
• Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study (2025 · Journal of Clinical Oncology · 被引 44)
• Nab -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer (2024 · NEJM Evidence · 被引 25)
• The HLA-B7 allele confers susceptibility to breast cancer in Spanish women (2005 · Immunology Letters · 被引 20)